-
Report: Countries, Companies Risk Billions in Race for Coronavirus Vaccine
“The crisis in the world is so big that each of us will have to take maximum risk now to put this disease to a stop,” said Paul Stoffels, chief scientific officer at Johnson & Johnson, which has partnered with the U.S. government on a $1 billion investment to speed development and production of its still-unproven vaccine. “If it fails,” Stoffels told Reuters, “it will be bad.”
- Categories
- Coronavirus, Health Care
- Region
- North America
-
Big Pharma’s Blindspot: Before COVID-19, Vaccine and Antiviral Research Went Neglected
Public health experts have warned for years that the world is at risk of a major pandemic, and advocates say Big Pharma showed little interest in developing vaccines — or even antibiotic and antiviral medications — until the latest outbreak offered an opportunity to rake in public funding and turn out massive profits with minimal risk.
- Categories
- Coronavirus, Health Care
-
Delivering Family Planning to Rural Customers: Are Mobile Pharmacies ‘Just What the Doctor Ordered’?
Pharmacies serve as key access points for family planning products in many emerging markets. In countries like Malawi, the number of pharmacies has ballooned by nearly 100% in the past 10 years. Yet it can be difficult to run a sustainable pharmacy business, especially in rural areas. Andrea Bare and Erika Beidelman at the William Davidson Institute discuss potential solutions – including an innovative mobile pharmacy – based on conversations with Malawian entrepreneurs.
- Categories
- Entrepreneurship, Health Care
-
Press Release: FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis
"FDA approval of this treatment represents a victory for the people suffering from these highly drug-resistant forms of the world's deadliest infectious disease," said Mel Spigelman, MD, president and CEO of TB Alliance. "The associated novel regimen will hopefully provide a shorter, more easily manageable and highly efficacious treatment for those in need."
- Categories
- Health Care
-
Drug Prices Can Take A Surprising Turn When A Poor Country Gets Richer
A new report, published by the Center for Global Development in June, finds that as countries move up the ladder of economic development, it becomes harder for government agencies, hospitals and health care companies to buy drugs at reasonable prices.
- Categories
- Health Care
-
In Quest for Universal Health Coverage, Kenya Faces Pharmacy Regulation Battles
A 2014 “Kenya Household Health Expenditure and Utilisation Survey” found that private clinics and pharmacies were the main private providers and that they accounted for 23% of all outpatient visits. Others have produced even higher estimates.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Ghana’s Budding Health Tech Sector is Finally Getting Deserved Global Recognition
Ghana’s long unsung health tech sector is getting global validation with two of its most promising startups being named among five winners for one of the most prestigious social enterprise awards in the world.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
Parent Organization
